Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Liothyronine Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 6 USDMF, 3 CEP/COS, 1 JDMF, 4 EU WC, 1 KDMF, 7 NDC API, 4 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

50 FDF Dossiers, 28 FDA Orange Book, 8 Europe, 4 Canada, 2 Australia, 3 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 0.005MG BASE, TABLET;ORAL - EQ 0.025MG BASE, TABLET;ORAL - EQ 0.05MG BASE, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 18 SPI Pharma, 8 DKSH, 5 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 2 Pfanstiehl, 4 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 28 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 26 Direct Compression, 24 Thickeners and Stabilizers, 20 Taste Masking, 20 Controlled & Modified Release, 19 Lubricants & Glidants, 17 Chewable & Orodispersible Aids, 15 Granulation, 13 Co-Processed Excipients, 12 Disintegrants & Superdisintegrants, 9 Empty Capsules, 9 Film Formers & Plasticizers, 8 Parenteral, 4 API Stability Enhancers, 4 Solubilizers, 4 Emulsifying Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 2 Topical

DIGITAL CONTENT

27 News #PharmaBuzz

27 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 19 Regulatory FDF Prices

MARKET PLACE

17 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	Azico Biophore India Pvt. Ltd	India	AZICO BIOPHORE INDIA PVT LTD	30942	LIOTHYRONINE SODIUM	2016-09-30	Active	II	Complete	2017-03-22	2016-09-29
28/03/2025	GSK	United Kingdom	SMITH KLINE & FRENCH LABS DIV SMITHKLINE BECKMAN CORP	624	CYTOMEL IMPLANT PELLETS (VET)	1963-04-25	Inactive	II	N/A

Liothyronine Sodium

Liothyronine Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers

6 USDMF

3 CEP/COS

1 JDMF

4 EU WC

1 KDMF

7 NDC API

4 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

50 FDF Dossiers

28 FDA Orange Book

8 Europe

4 Canada

2 Australia

3 South Africa

5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 0.005MG BASE

TABLET;ORAL - EQ 0.025MG BASE

TABLET;ORAL - EQ 0.05MG BASE

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

18 SPI Pharma

8 DKSH

5 Faran Shimi Pharmaceutical

4 Gangwal Healthcare

2 Pfanstiehl

4 ACG Worldwide

2 Actylis

1 Aeon Procare

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

10 Corel Pharma Chem

2 DFE Pharma

6 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

17 Kerry

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

1 Novo Excipients

1 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

28 Roquette

7 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders

44 Coating Systems & Additives

26 Direct Compression

24 Thickeners and Stabilizers

20 Taste Masking

20 Controlled & Modified Release

19 Lubricants & Glidants

17 Chewable & Orodispersible Aids

15 Granulation

13 Co-Processed Excipients

12 Disintegrants & Superdisintegrants

9 Empty Capsules

9 Film Formers & Plasticizers

8 Parenteral

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons